Sionna Therapeutics, Inc.
SION
$39.46
$0.451.15%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -70.68M | -75.84M | -66.32M | -61.69M | -57.72M |
| Total Depreciation and Amortization | 662.00K | 642.00K | 661.00K | 668.00K | 662.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.78M | 13.97M | 12.17M | 11.31M | 11.69M |
| Change in Net Operating Assets | 786.00K | -2.69M | -2.41M | -3.08M | -3.09M |
| Cash from Operations | -61.45M | -63.91M | -55.90M | -52.79M | -48.46M |
| Capital Expenditure | -200.00K | -113.00K | -113.00K | -27.00K | -122.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -125.91M | -138.69M | -144.07M | -126.89M | -134.89M |
| Cash from Investing | -126.11M | -138.80M | -144.18M | -126.91M | -135.01M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 204.39M | 202.49M | 202.53M | 141.00K | 116.00K |
| Repurchase of Common Stock | -312.00K | -312.00K | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 0.00 | 181.33M | 181.33M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.43M | -2.50M | -2.50M | -2.50M | -1.07M |
| Cash from Financing | 202.64M | 199.67M | 200.02M | 178.97M | 180.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.08M | -3.04M | -57.00K | -733.00K | -3.10M |